These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 7737670

  • 21. A protective anti-peptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence.
    Barnett PV, Pullen L, Staple RF, Lee LJ, Butcher R, Parkinson D, Doel TR.
    J Gen Virol; 1996 May; 77 ( Pt 5)():1011-8. PubMed ID: 8609466
    [Abstract] [Full Text] [Related]

  • 22. Monoclonal antibodies against synthetic sequences of the nicotinic receptor cross-react fully with the native receptor and reveal the transmembrane disposition of their epitopes.
    Lei S, Raftery MA, Conti-Tronconi BM.
    Biochemistry; 1993 Jan 12; 32(1):91-100. PubMed ID: 7678197
    [Abstract] [Full Text] [Related]

  • 23. Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of human immunodeficiency virus type 1.
    Langedijk JP, Back NK, Durda PJ, Goudsmit J, Meloen RH.
    J Gen Virol; 1991 Oct 12; 72 ( Pt 10)():2519-26. PubMed ID: 1919529
    [Abstract] [Full Text] [Related]

  • 24. Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatments.
    Oggero M, Frank R, Etcheverrigaray M, Kratje R.
    Mol Divers; 2004 Oct 12; 8(3):257-69. PubMed ID: 15384419
    [Abstract] [Full Text] [Related]

  • 25. Kinetics of development and characteristics of antibodies induced in cancer patients against yeast expressed rDNA derived granulocyte macrophage colony stimulating factor (GM-CSF).
    Rini B, Wadhwa M, Bird C, Small E, Gaines-Das R, Thorpe R.
    Cytokine; 2005 Jan 21; 29(2):56-66. PubMed ID: 15598439
    [Abstract] [Full Text] [Related]

  • 26. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, Guo MS, Chow YH, Yang WS, Chang KH, Sia C, Chong P.
    Vaccine; 2011 Jun 10; 29(26):4362-72. PubMed ID: 21501643
    [Abstract] [Full Text] [Related]

  • 27. Production and characterization of monoclonal antibodies to human ciliary neurotrophic factor with defined epitope recognition.
    Cazzola F, Battiston S, Fabris M, Negro A, Soranzo C, Corona G, Callegaro L.
    Hybridoma; 1993 Jun 10; 12(3):259-70. PubMed ID: 7689533
    [Abstract] [Full Text] [Related]

  • 28. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM, Buratti E, Jones TD, North P, Baralle F, McLain L, McInerney T, Durrani Z, Dimmock NJ.
    Virology; 2000 Jan 05; 266(1):66-78. PubMed ID: 10612661
    [Abstract] [Full Text] [Related]

  • 29. Cytokeratin peptide SFGSGFGGGY mimics N-acetyl-beta-D-glucosamine in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response.
    Shikhman AR, Greenspan NS, Cunningham MW.
    J Immunol; 1994 Dec 15; 153(12):5593-606. PubMed ID: 7527445
    [Abstract] [Full Text] [Related]

  • 30. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
    Egan MA, Chong SY, Hagen M, Megati S, Schadeck EB, Piacente P, Ma BJ, Montefiori DC, Haynes BF, Israel ZR, Eldridge JH, Staats HF.
    Vaccine; 2004 Sep 09; 22(27-28):3774-88. PubMed ID: 15315859
    [Abstract] [Full Text] [Related]

  • 31. Neutralizing and nonneutralizing monoclonal antibodies to the human granulocyte-macrophage colony-stimulating factor receptor alpha-chain.
    Nicola NA, Wycherley K, Boyd AW, Layton JE, Cary D, Metcalf D.
    Blood; 1993 Sep 15; 82(6):1724-31. PubMed ID: 8400229
    [Abstract] [Full Text] [Related]

  • 32. Immunodominant B-cell epitope in the Mce1A mammalian cell entry protein of Mycobacterium tuberculosis cross-reacting with glutathione S-transferase.
    Harboe M, Das AK, Mitra D, Ulvund G, Ahmad S, Harkness RE, Das D, Mustafa AS, Wiker HG.
    Scand J Immunol; 2004 Feb 15; 59(2):190-7. PubMed ID: 14871296
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Epitope mapping of the V3 domain of feline immunodeficiency virus envelope glycoprotein by monoclonal antibodies.
    Lombardi S, Massi C, Tozzini F, Zaccaro L, Bazzichi A, Bandecchi P, La Rosa C, Bendinelli M, Garzelli C.
    J Gen Virol; 1995 Aug 15; 76 ( Pt 8)():1893-9. PubMed ID: 7636470
    [Abstract] [Full Text] [Related]

  • 40. Fine mapping of canine parvovirus B cell epitopes.
    López de Turiso JA, Cortés E, Ranz A, García J, Sanz A, Vela C, Casal JI.
    J Gen Virol; 1991 Oct 15; 72 ( Pt 10)():2445-56. PubMed ID: 1919526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.